Home NDC 70377-050 Lenalidomide
Product NDC 70377-050
11-digit product format 703770050
Labeler code 70377
Product ID 70377-050_356a3872-0df8-ff66-7ebc-ac8109186f86
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Lenalidomide
Dosage form CAPSULE
Route ORAL
Labeler BIOCON PHARMA INC.,
Application ANDA215759
Marketing category ANDA
Marketing start 2025-03-03
Substance LENALIDOMIDE
Active strength 5 mg/1
Pharmacologic classes Thalidomide Analog [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A215759-001 LENALIDOMIDE LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2025-03-03 A215759-002 LENALIDOMIDE LENALIDOMIDE 5MG CAPSULE / ORAL AB 2025-03-03 A215759-003 LENALIDOMIDE LENALIDOMIDE 10MG CAPSULE / ORAL AB 2025-03-03 A215759-004 LENALIDOMIDE LENALIDOMIDE 15MG CAPSULE / ORAL AB 2025-03-03 A215759-005 LENALIDOMIDE LENALIDOMIDE 20MG CAPSULE / ORAL AB 2025-03-03 A215759-006 LENALIDOMIDE LENALIDOMIDE 25MG CAPSULE / ORAL AB 2025-03-03
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 48 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A215759-001 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2025-03-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 A215759-002 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2025-03-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 A215759-003 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2025-03-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 A215759-004 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2025-03-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 A215759-005 LENALIDOMIDE 20MG CAPSULE / ORAL AB 2025-03-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 A215759-006 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2025-03-03 c2088c7a36db…2026-09-14 22:38:34 2026-08 A215759-001 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2025-03-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215759-002 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2025-03-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215759-003 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2025-03-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215759-004 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2025-03-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215759-005 LENALIDOMIDE 20MG CAPSULE / ORAL AB 2025-03-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215759-006 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2025-03-03 84e616aacf4f…2026-08-18 06:07:40 2026-07 A215759-001 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2025-03-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215759-002 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2025-03-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215759-003 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2025-03-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215759-004 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2025-03-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215759-005 LENALIDOMIDE 20MG CAPSULE / ORAL AB 2025-03-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215759-006 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2025-03-03 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A215759-001 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2025-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215759-002 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2025-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215759-003 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2025-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215759-004 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2025-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215759-005 LENALIDOMIDE 20MG CAPSULE / ORAL AB 2025-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215759-006 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2025-03-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215759-001 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2025-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215759-002 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2025-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215759-003 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2025-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215759-004 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2025-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215759-005 LENALIDOMIDE 20MG CAPSULE / ORAL AB 2025-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215759-006 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2025-03-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A215759-001 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2025-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215759-002 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2025-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215759-003 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2025-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215759-004 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2025-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215759-005 LENALIDOMIDE 20MG CAPSULE / ORAL AB 2025-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215759-006 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2025-03-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215759-001 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2025-03-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215759-002 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2025-03-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215759-003 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2025-03-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215759-004 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2025-03-03 fd3edfee7708…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 48 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Lenalidomide
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LENALIDOMIDE 5 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70377-050-12 Lenalidomide 100 in 1 BOTTLE CAPSULE 100 9 70377-050-13 Lenalidomide 28 in 1 BOTTLE CAPSULE 28 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70377-050 LENALIDOMIDE CAPSULE [BIOCON PHARMA INC.,] 9 Current NDC, 2 package rows 20250306_ed7a3099-ce31-4865-b212-358d9ff6261b.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 70377-050-12 70377005012 100 CAPSULE in 1 BOTTLE (70377-050-12) 100 capsule 2025-03-03 No No Current 70377-050-13 70377005013 28 CAPSULE in 1 BOTTLE (70377-050-13) 28 capsule 2025-03-03 No No Current